On June 27, 2016, the U.S. Supreme Court granted review of a case on whether Section 271(f)(1) is violated by providing a single component abroad which when combined with other components would induce infringement if combined in the United States. Life Tech. Corp. v. Promega Corp., No. 14-1538, 6/27/16. The Court denied review of a Federal Circuit decision that an important medical diagnostic method is ineligible for patent protection under Section 101. Sequenom, Inc. v. Ariosa Diagnostics, Inc., No. 15-1182, 6/27/16.
Disclaimer: The content in this blog is solely for informational purposes and does not constitute legal advice.